In contrast to cardiorenal syndrome ... should the enhancement of cardiovascular death initiated by kidney disease be termed 'renocardiac syndrome'? As the kidney is the primary regulator of ...

Cardiorenal syndrome (CRS) commonly occurs during treatment of acute decompensated heart failure (ADHF) and is associated with poor clinical outcome. The pathophysiology of CRS entails a complex ...

Figure 1: The pathophysiology of the cardiorenal syndrome and its effect ... and in the perioperative stage for surgical patients. Several studies that aim to define the role of EPO treatment ...

Aims We sought to assess the prevalence and clinical correlates of cardiorenal anaemia (CRA) syndrome in systolic heart failure and the relationship between renal dysfunction and anaemia on hard ...

The first kidney or cardiorenal outcome trial with an SGLT2 inhibitor, CREDENCE, was done in patients with type 2 diabetes, mostly because canagliflozin (Invokana, Janssen) was already on the ...

The cardiorenal benefits of sodium-glucose cotransporter ... The composite renal outcome was defined as progression to end stage renal disease, doubling of serum creatinine, initiation of renal ...